The National Comprehensive Cancer Network (NCCN) Oncology Research Program (OPR) will support a Phase II randomized trial for lung cancer patients titled TH-138. Joseph Treat, MD, Professor, Department of Hematology/Oncology, Fox Chase Cancer Center will serve as...
NCCN
Category
NCCN® 2019 in San Francisco: Latest Treatment Innovations for Hematologic Malignancies
World-renowned experts on blood cancers are meeting in San Francisco on September 27-28 to help clinicians stay up-to-date on new, practice changing strategies to manage patients with hematologic malignancies at the NCCN 2019 Annual Congress: Hematologic Malignancies™...
NCCN Awards Grants to Investigators to Study Trifluridine & Tipiracil
P&T Community reports that the National Comprehensive Cancer Network (NCCN) Oncology Research Program has awarded grants to three clinical investigators from NCCN member institutions through a collaborative scientific research relationship with Taiho Oncology,...